Professional Documents
Culture Documents
& Cycloaddition
Abstract: The tetrakisimidazolium salt H4-2(Br)4, featuring a lamp connects the two tetra-NHC ligands through four cy-
central benzene linker and 1,2,4,5-(nBu-imidazolium-Ph-CH= clobutane linkers to give compound [4](BF4)4. Removal of
CH-) substituents reacts with Ag2O in the presence of AgBF4 the template metals yields the novel oktakisimidazolium salt
to yield the tetranuclear, oktakis-NHC assembly [3](BF4)4. H8-5(BF4)8. The tetrakisimidazolium salt H4-2(BF4)4 and the ok-
Cation [3]4 + features four pairs of olefins from the two tetra- takisimidazolium salt H8-5(BF4)8 have been used as multiva-
kis-NHC ligands perfectly arranged for a subsequent [2+ +2] lent anion receptors and their anion binding properties to-
cycloaddition. Irradiation of [3](BF4)4 with a high pressure Hg wards six different anions have been compared.
Chem. Eur. J. 2020, 26, 11565 – 11570 11565 T 2020 The Authors. Published by Wiley-VCH GmbH
Full Paper
Chemistry—A European Journal doi.org/10.1002/chem.202001515
Chem. Eur. J. 2020, 26, 11565 – 11570 www.chemeurj.org 11566 T 2020 The Authors. Published by Wiley-VCH GmbH
Full Paper
Chemistry—A European Journal doi.org/10.1002/chem.202001515
Chem. Eur. J. 2020, 26, 11565 – 11570 www.chemeurj.org 11567 T 2020 The Authors. Published by Wiley-VCH GmbH
Full Paper
Chemistry—A European Journal doi.org/10.1002/chem.202001515
Chem. Eur. J. 2020, 26, 11565 – 11570 www.chemeurj.org 11568 T 2020 The Authors. Published by Wiley-VCH GmbH
Full Paper
Chemistry—A European Journal doi.org/10.1002/chem.202001515
binding mode, in which K11 = 4K12), or not (cooperative, K11 ¼ 6 midazolium building blocks H4-2(BF4)4. The intermediate octa-
4K12).[7a] This is an important point to consider, because it de- kis-NHC complex [4](BF4)4 with four cyclobutane linkers fea-
termines how many parameters will need to be fitted during tures two non-planar central benzene groups. The tetrakis-
the regression fitting process,[14] and this can be used to assess and the octakisimidazolium salts were tested as multivalent re-
the reliability of the result. ceptors of six different anions, including two with relevant bio-
As can be seen from the data in Table 1, the binding con- logical and medical significance (ATP@ and IBF@). From our
stants obtained for the tetrakisimidazolium salt H4-2(BF4)4, did study, we concluded that the octakisimidazolium salt exhibited
not differ much regardless of whether we used a cooperative a larger binding affinity for all six anions tested. Given that we
or non-cooperative binding model (entries 1–6). This allows us did not find reasons to conclude that the stepwise binding of
to assume that the binding of the anions followed a non-coop- the anions followed a cooperative model, we believe that the
erative binding model, and this was the model that we used enhancement of the binding affinity should be ascribed to the
for the determination of the association constants when the larger electrostatic attraction produced between the anionic
octakisimidazolium salt H8-5(BF4)8 was used (entries 7–12). The guests and the octacationic octakisimidazolium receptor com-
data reflect that the affinities shown for chloride are higher pared to the tetracationic tetrakisimidazolium one. With our
than that shown for bromide, in agreement with the larger ba- work we proved that the template-controlled preparation of
sicity of the former one. Both receptors show larger affinities polyimidazolium salts offers a unique opportunity to generate
for carboxylates and ATP@ . The two carboxylate anions (ben- multivalent receptors with enhanced recognition abilities.
zoate and IBF@) exhibited a rather similar affinity and the bind-
ing constant shown for ATP@ was the largest found for both re-
ceptors, therefore showing large selectivity for this anion. The Experimental
larger affinities observed for phosphate anions when polyazoli- Full details of synthesis and characterisation can be found in the
um receptors are used have been observed before.[15] It is im- Supporting Information.
portant to point out, that for all anions tested, we found that Deposition Numbers 1972486 ([3](BF4)2(BPh4)2·4 MeCN), and
the affinities for the octakisimidazolium receptor H8-5(BF4)8 1972487 ([4](BPh4)4) contain the supplementary crystallographic
were between 3–8 times larger than those obtained when H4- data for this paper. These data are provided free of charge by the
2(BF4)4 was used. joint Cambridge Crystallographic Data Centre and Fachinforma-
tionszentrum Karlsruhe Access Structures service www.ccdc.cam.a-
c.uk/structures.
Entry Host Guest K11 [M@1] K12 [M@1] F.E.H. acknowledges financial support from the DFG (SFB 858
1 H4-2(BF4)4 ATP -
1.60(2) V 10 3[a]
4.0 V 102 and IRTG 2027). E.P. and M.P. acknowledge financial support
1.7(1) V 103[b] 2.5(2) V 102[b] from the Ministerio de Ciencia y Universidades (PGC2018-
2 H4-2(BF4)4 benzoate 200(4)[a] 49 093382-B-I00) and the Universitat Jaume I (UJI-B2017-07 and
290(8)[b] 34(2)[b] UJI-2028-46). E.P. and M.P. are grateful to the Serveis Centrals
3 H4-2(BF4)4 Cl- 70(1)[a] 18
60(2)[b] N/A[b]
d’Instrumentacij Cient&fica (SCIC-UJI) for providing spectro-
4 H4-2(BF4)4 Br- 45(1)[a] 10 scopic facilities and to the Alexander von Humboldt Founda-
40(1)[b] N/A[b] tion for a Humboldt Research Award to E.P. Open access fund-
5 H4-2(BF4)4 NO3@ 31(1)[a] 8 ing enabled and organized by Projekt DEAL.
29(1)[b] N/A[b]
6 H4-2(BF4)4 IBF- 133(2)[a] 33
91(1)[b] N/A[b]
7 H8-5(BF4)8 ATP- 8.4(4) V 103 2.1 V 103
Conflict of interest
8 H8-5(BF4)8 benzoate 7.4(1) V 102 1.8 V 102
9 H8-5(BF4)8 Cl- 4.53(5) V 102 1.25 V 102 The authors declare no conflict of interest.
10 H8-5(BF4)8 Br- 86(3) 21(1)
11 H8-5(BF4)8 NO3- 390(9) 98(2)
12 H8-5(BF4)8 IBF- 760(8) 190(2) V 102 Keywords: anion recognition · N-heterocyclic carbene ·
[a] Association constants calculated by global nonlinear regression analy-
polyimidazolium salts · postsynthetic photochemical
sis and assuming a non-cooperative 1:2 (H:G) binding model. All anions modification · silver complexes
added as tetrabutyl ammonium salts. [b] Association constants calculated
without parameter restrictions. N/A: the value resulting from the fitting [1] a) T. R. Cook, P. J. Stang, Chem. Rev. 2015, 115, 7001 – 7045; b) T. R. Cook,
was too small or did not have any physical meaning. Y.-R. Zhen, P. J. Stang, Chem. Rev. 2013, 113, 734 – 777; c) N. C. Gianne-
schi, M. S. Masar III, C. A. Mirkin, Acc. Chem. Res. 2005, 38, 825 – 837;
d) D. L. Caulder, K. N. Raymond, Acc. Chem. Res. 1999, 32, 975 – 982; e) R.
Chakrabarty, P. S. Mukherjee, P. J. Stang, Chem. Rev. 2011, 111, 6810 –
Conclusions 6918; f) A. M. Castilla, W. J. Ramsay, J. R. Nitschke, Acc. Chem. Res. 2014,
47, 2063 – 2073; g) A. J. McConnell, C. S. Wood, P. P. Neelakanda, J. R.
In summary, we have demonstrated the template synthesis of Nitschke, Chem. Rev. 2015, 115, 7729 – 7793; h) M. Fujita, K. Ogura,
the novel octakisimidazolium salt H8-5(BF4)8 from two tetrakisi- Coord. Chem. Rev. 1996, 148, 249 – 264; i) M. Fujita, Chem. Soc. Rev. 1998,
Chem. Eur. J. 2020, 26, 11565 – 11570 www.chemeurj.org 11569 T 2020 The Authors. Published by Wiley-VCH GmbH
Full Paper
Chemistry—A European Journal doi.org/10.1002/chem.202001515
27, 417 – 425; j) M. Han, D. M. Engelhard, G. H. Clever, Chem. Soc. Rev. Org. Biomol. Chem. 2005, 3, 4201 – 4208; i) P. Molina, F. Zapata, A. Cabal-
2014, 43, 1848 – 1860. lero, Chem. Rev. 2017, 117, 9907 – 9972.
[2] a) D. A. Roberts, B. S. Pilgrim, J. R. Nitschke, Chem. Soc. Rev. 2018, 47, [7] a) L. K. S. von Krbek, C. A. Schalley, P. Thordarson, Chem. Soc. Rev. 2017,
626 – 644; b) M.-M. Gan, J.-Q. Liu, L. Zhang, Y.-Y. Wang, F. E. Hahn, Y.-E. 46, 2622 – 2637; b) R. Haag, Beilstein J. Org. Chem. 2015, 11, 848 – 849;
Han, Chem. Rev. 2018, 118, 9587 – 9641; c) Y. Li, Y.-Y. An, J.-Z. Fan, X.-X. c) C. Fasting, C. A. Schalley, M. Weber, O. Seitz, S. Hecht, B. Koksch, J.
Liu, X. Li, F. E. Hahn, Y.-Y. Wang, Y.-F. Han, Angew. Chem. Int. Ed. 2020, 59, Dernedde, C. Graf, E.-W. Knapp, R. Haag, Angew. Chem. Int. Ed. 2012, 51,
10073 – 10080; Angew. Chem. 2020, 132, 10159 – 10166. 10472 – 10498; Angew. Chem. 2012, 124, 10622 – 10650; d) M. Mammen,
[3] a) K. K. Tanabe, S. M. Cohen, Chem. Soc. Rev. 2011, 40, 498 – 519; b) S. M. S.-K. Choi, G. M. Whitesides, Angew. Chem. Int. Ed. 1998, 37, 2754 – 2794;
Cohen, Chem. Rev. 2012, 112, 970 – 1000; c) Z. Wang, S. M. Cohen, Chem. Angew. Chem. 1998, 110, 2908 – 2953; e) S. Tashiro, M. Shionoya, Acc.
Soc. Rev. 2009, 38, 1315 – 1329; d) Z. Yin, S. Wan, J. Yang, M. Kurmoo, Chem. Res. 2020, 53, 632 – 643.
M. H. Zeng, Coord. Chem. Rev. 2019, 378, 500 – 512. [8] N. E. Wong, P. Ramaswamy, A. S. Lee, B. S. Gelfand, K. J. Bladek, J. M.
[4] N. Sinha, F. E. Hahn, Acc. Chem. Res. 2017, 50, 2167 – 2184. Taylor, D. M. Spasyuk, G. K. H. Shimizu, J. Am. Chem. Soc. 2017, 139,
[5] a) L. Zhang, R. Das, C.-T. Li, Y.-Y. Wang, F. E. Hahn, K. Hua, L.-Y. Sun, Y.-F. 14676 – 14683.
Han, Angew. Chem. Int. Ed. 2019, 58, 13360 – 13364; Angew. Chem. 2019, [9] Z. Zheng, Z. Yu, M. Yang, F. Jin, Q. Zhang, H. Zhou, J. Wu, Y. Tian, J. Org.
131, 13494 – 13498; b) L.-L. Ma, Y.-Y. An, L.-Y. Sun, Y.-Y. Wang, F. E. Hahn, Chem. 2013, 78, 3222 – 3234.
Y.-E. Han, Angew. Chem. Int. Ed. 2019, 58, 3986 – 3991; Angew. Chem. [10] G. M. J. Schmidt, Pure Appl. Chem. 1971, 27, 647 – 678.
2019, 131, 4026 – 4031; c) L.-Y. Sun, N. Sinha, T. Yan, Y.-S. Wang, T. T. Y. [11] N. Sinha, L. Stegemann, T. T. Y. Tan, N. L. Doltsinis, C. A. Strassert, F. E.
Tan, L. Yu, Y.-F. Han, F. E. Hahn, Angew. Chem. Int. Ed. 2018, 57, 5161 – Hahn, Angew. Chem. Int. Ed. 2017, 56, 2785 – 2789; Angew. Chem. 2017,
5165; Angew. Chem. 2018, 130, 5256 – 5261; d) T. Yan, L.-Y. Sun, Y.-X. 129, 2829 – 2833.
Deng, Y.-F. Han, G.-X. Jin, Chem. Eur. J. 2015, 21, 17610 – 17613; e) Y.-F. [12] a) A. J. Lowe, F. M. Pfeffer, P. Thordarson, Supramol. Chem. 2012, 24,
Han, G.-X. Jin, C. G. Daniliuc, F. E. Hahn, Angew. Chem. Int. Ed. 2015, 54, 585 – 594; b) P. Thordarson, Chem. Soc. Rev. 2011, 40, 1305 – 1323.
4958 – 4962; Angew. Chem. 2015, 127, 5042 – 5046; f) Y.-F. Han, G.-X. Jin, [13] a) F. Ulatowski, K. Da˛browa, T. Bałakier, J. Jurczak, J. Org. Chem. 2016, 81,
F. E. Hahn, J. Am. Chem. Soc. 2013, 135, 9263 – 9266. 1746 – 1756; b) D. B. Hibbert, P. Thordarson, Chem. Commun. 2016, 52,
[6] a) Y. Liu, W. Zhao, C.-H. Chen, A. H. Flood, Science 2019, 365, 159 – 161; 12792 – 12805.
b) F. D’Anna, R. Noto, Eur. J. Org. Chem. 2014, 4201 – 4223; c) J. Cai, J. L. [14] E. N. W. Howe, M. Bhadbhade, P. Thordarson, J. Am. Chem. Soc. 2014,
Sessler, Chem. Soc. Rev. 2014, 43, 6198 – 6213; d) K. Sato, S. Arai, T. Yama- 136, 7505 – 7516.
gishi, Tetrahedron Lett. 1999, 40, 5219 – 5222; e) E. Alcalde, C. Alvarenz- [15] S. Ruiz-Botella, P. Vidossich, G. Ujaque, E. Peris, P. D. Beer, RSC Adv. 2017,
Rffla, S. Garc&a-Granda, E. Garc&a-Rodriguez, N. Mesquida, L. P8rez-Garc&a, 7, 11253 – 11258.
Chem. Commun. 1999, 295 – 296; f) H. Ihm, S. Yun, H. G. Kim, J. K. Kim,
K. S. Kim, Org. Lett. 2002, 4, 2897 – 2900; g) V. Amendola, M. Boiocchi, B.
Colasson, L. Fabbrizzi, M.-J. Rodriguez Douton, F. Ugozzoli, Angew. Manuscript received: March 30, 2020
Chem. Int. Ed. 2006, 45, 6920 – 6924; Angew. Chem. 2006, 118, 7074 – Accepted manuscript online: April 1, 2020
7078; h) W. W. H. Wong, M. S. Vickers, A. R. Cowley, R. L. Paul, P. D. Beer, Version of record online: August 6, 2020
Chem. Eur. J. 2020, 26, 11565 – 11570 www.chemeurj.org 11570 T 2020 The Authors. Published by Wiley-VCH GmbH